Oral morphine versus transmucosal diamorphine for breakthrough pain in children: methods and outcomes: UK (DIPPER

Emily Harrop1,2, Christina Liossi3,4, Liz Jamieson5,6

  • 1Helen and Douglas House Hospice, Oxford, UK.

Insights

Consensus was reached on using the buccal route for transmucosal diamorphine to manage breakthrough pain in children. Standardized pain scales were chosen to inform future pediatric palliative care trials.

Area of Science:

  • Palliative Care
  • Pediatric Pain Management
  • Clinical Trial Design

Background:

  • No randomized controlled trials exist for breakthrough pain in pediatric palliative care.
  • Standardized outcome measures for pediatric breakthrough pain are lacking.
  • This study aimed to inform a future randomized controlled trial on opioid administration for breakthrough pain in children.

Purpose of the Study:

  • To achieve consensus on design aspects for a prospective study.
  • To inform a future randomized controlled trial comparing oral morphine and transmucosal diamorphine.
  • To establish feasibility for a randomized controlled trial in pediatric palliative care.

Main Methods:

  • Nominal group technique used to achieve consensus.
  • Expert panel included 10 clinicians and 3 parent representatives.
  • Consensus defined as agreement with no further participant comments.

Main Results:

  • The buccal route was favored for administration.
  • Dosing followed the Association for Paediatric Palliative Medicine formulary.
  • The verbal Numerical Rating Scale, Faces Pain Scale-Revised, and FLACC/FLACC-Revised were selected for pain measurement.

Conclusions:

  • Consensus was reached for a small-scale prospective cohort study.
  • The study provides essential information for designing a future randomized controlled trial.
  • This work addresses the need for standardized outcome measures in pediatric palliative care.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
499
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
448
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
917
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
32